Nivestym Injection, Solution
Product Images NDC 0069-0293

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 44 technical images submitted to the FDA as part of the official labeling for Nivestym (NDC 0069-0293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Nivestym 01)

Logo (Nivestym 01)
The text contains only two fragments of text which are not enough to provide a useful description. The first fragment includes the characters "P zer" and the second fragment includes the word "Oncology". Without further context, it is not possible to generate a description or to infer what the text is referring to.*
FDA Label Image

Logo (Nivestym 02)

FDA Label Image

Figure A (Nivestym 03)

Figure A (Nivestym 03)
Not available.*
FDA Label Image

Figure B (Nivestym 04)

Figure B (Nivestym 04)
This text describes an alcohol wipe cotton ball, an adhesive bandage, and a sharps disposal container, likely related to medical or first aid use.*
FDA Label Image

Figure C (Nivestym 05)

FDA Label Image

Figure D (Nivestym 06)

FDA Label Image

Figure E (Nivestym 07)

Figure E (Nivestym 07)
This appears to be a list of body parts including the stomach area, thigh, upper arm, and buttocks.*
FDA Label Image

Figure F (Nivestym 08)

FDA Label Image

Figure G (Nivestym 09)

FDA Label Image

Figure H (Nivestym 10)

FDA Label Image

Figure I (Nivestym 11)

FDA Label Image

Figure J (Nivestym 12)

FDA Label Image

Figure K (Nivestym 13)

FDA Label Image

Figure L (Nivestym 14)

FDA Label Image

Figure M (Nivestym 15)

FDA Label Image

Figure N (Nivestym 16)

FDA Label Image

Figure O (Nivestym 17)

FDA Label Image

Figure P (Nivestym 18)

FDA Label Image

Logo (Nivestym 19)

FDA Label Image

Figure (Nivestym 20)

Figure (Nivestym 20)
The text describes a disposable syringe that has a plunger.*
FDA Label Image

Figure (Nivestym 21)

FDA Label Image

Figure (Nivestym 22)

FDA Label Image

Figure (Nivestym 23)

FDA Label Image

Figure (Nivestym 24)

FDA Label Image

Figure (Nivestym 25)

FDA Label Image

Figure (Nivestym 26)

Figure (Nivestym 26)
This is a list of body parts: Upper arm, abdomen, buttocks, and thigh.*
FDA Label Image

Figure (Nivestym 27)

FDA Label Image

Figure (Nivestym 28)

FDA Label Image

Figure (Nivestym 29)

FDA Label Image

Figure (Nivestym 30)

FDA Label Image

Figure (Nivestym 31)

FDA Label Image

Logo (Nivestym 32)

Logo (Nivestym 32)
This text is not clear and cannot be evaluated without more context.*
FDA Label Image

Principal Display Panel (1 mL Vial Label)

Principal Display Panel (1 mL Vial Label)
Nivestym is a prescription drug that comes in a 1 mL single-dose vial. It contains filgrastim-aafi and is distributed by Pfizer Labs, a division of Pfizer Inc. It is recommended to store the medication at 2°C to 8°C. The dosage information can be found on the package. The drug is produced by Hospira, Inc. and is a biosimilar. The US License number for this medication is 1974.*
FDA Label Image

Principal Display Panel (1 mL Vial Carton)

Principal Display Panel (1 mL Vial Carton)
Nivestym is a medication that comes in the form of an injection with no preservatives. The provided text also contains various identification numbers, possibly for inventory or tracking purposes, and some illegible characters.*
FDA Label Image

Principal Display Panel (1.6 mL Vial Label)

Principal Display Panel (1.6 mL Vial Label)
This is a medication called Nivestym (filgrastim-aafi) Injection that is manufactured by Hospira, Inc. The dosage instructions are on the package. It is important to store it at 2°08°C. The medication comes in a 1.6 mL single-dose vial and is distributed by Pfizer Labs. This medication is a biosimilar. The text includes a reference number of RL10065.*
FDA Label Image

Principal Display Panel (1.6 mL Vial Carton)

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Principal Display Panel (0.5 mL Syringe Label)
This text describes a medication called 'filgrastim-aafi' which is sold as a single dose in a syringe. It is for subcutaneous use only and produced by the company 'Hospialnc'. The medication has a concentration of 300mg/0.5mL and comes in a BTV container. The text includes a license number and a production date but does not include any information on the medical uses or side effects of the medication.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Principal Display Panel (0.5 mL Syringe Carton)
This appears to be a product description for a single-dose prefilled syringe with a needle guard. The syringe contains a sterile solution with recombinant Granulocyte Colony Stimulating factor (G-CSF) derived from E. coli. It is for subcutaneous use only and should be discarded if unused. The product is called ivestym™ (filgrastim-aafi) Injection and comes in a 300 mogh.5ml dose.*
FDA Label Image

Principal Display Panel (0.8 mL Syringe Label)

Principal Display Panel (0.8 mL Syringe Label)
This appears to be the label or packaging information for a medication called "Neulastim" or "Filgrastim-aafi" for subcutaneous use only. It includes the manufacturer's name and license number, as well as production and expiration information, but does not provide information on the medication's purpose or effects.*
FDA Label Image

Principal Display Panel (0.8 mL Syringe Carton)

FDA Label Image

Principal Display Panel (0.8 mL Syringe Carton)

Principal Display Panel (0.8 mL Syringe Carton)
Nivestym is a sterile solution injection of 480 mcg/0.8 mL Filgrastim-aafi, a recombinant Granulocyte Colony Stimulating Factor derived from E. coli, for subcutaneous use only. It is a single-dose prefilled syringe with needle guard. The unused portion should be discarded, and the solution has no preservative.*
FDA Label Image

Principal Display Panel (0.8 mL Sryinge Carton)

Principal Display Panel (0.8 mL Sryinge Carton)
This appears to be a mixture of outputs and does not make a coherent description. The text does not appear to be readable and may need to be rescanned or checked for any errors during transcription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.